Nurix Therapeutics Inc (NRIX) — Financial Flexibility Index
Nurix Therapeutics Inc (NRIX) has a Financial Flexibility Index of -0.36x as of August 2025. Free cash flow of $-54.67 Million (operating CF $-57.38 Million minus capex $2.71 Million) represents 0% of total liabilities ($150.22 Million). Check Nurix Therapeutics Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Nurix Therapeutics Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Nurix Therapeutics Inc across 7 annual periods. For the full cash flow conversion analysis, see NRIX cash generation efficiency.
Annual Financial Flexibility Index for Nurix Therapeutics Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Nurix Therapeutics Inc. Explore Nurix Therapeutics Inc (NRIX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.15x | $-163.31 Million | $-172.58 Million | $142.35 Million | ▼ -143.9% |
| 2023 | -0.47x | $-72.96 Million | $-81.36 Million | $155.10 Million | ▲ +64.0% |
| 2022 | -1.31x | $-147.56 Million | $-159.81 Million | $113.06 Million | ▼ -123.0% |
| 2021 | -0.59x | $-78.70 Million | $-84.36 Million | $134.47 Million | ▼ -1488.0% |
| 2020 | 0.04x | $4.47 Million | $-80.00K | $106.07 Million | ▲ +0.3% |
| 2019 | 0.04x | $2.25 Million | $601.00K | $53.57 Million | ▲ +104.8% |
| 2018 | -0.88x | $-30.08 Million | $-31.68 Million | $34.05 Million | — |